Hipther Artificial Intelligence

Roboticulized digests/handpicks the latest news about the artificial intelligence/machine learning industry and serves them to you daily. We provide you with the latest news and press releases straight from the AI/ML industry.
hvr-partners-with-databricks-to-drive-business-value-with-real-time-data-delivery

HVR Partners with Databricks to Drive Business Value with Real-Time Data Delivery

singapore-data-center-market-report-2021:-investment-analysis-and-growth-opportunities-–-market-will-witness-investments-of-$5-billion-by-2026

Singapore Data Center Market Report 2021: Investment Analysis and Growth Opportunities – Market will Witness Investments of $5 Billion by 2026

realeyes-announces-attention-data-api-for-predicting-in-market-outcomes-of-video-advertising

Realeyes Announces Attention Data API for Predicting In-Market Outcomes of Video Advertising

homeland-security-and-emergency-management-market-worth-$904.6-billion-by-2026-–-exclusive-report-by-marketsandmarkets

Homeland Security and Emergency Management Market worth $904.6 billion by 2026 – Exclusive Report by MarketsandMarkets™

global-workforce-iam-disruptive-technologies-and-unified-access-solutions-enable-robust-security-postures

Global Workforce IAM-Disruptive Technologies and Unified Access Solutions Enable Robust Security Postures

emerging-markets-report:-big-names-and-big-deals

Emerging Markets Report: Big Names and Big Deals

boston-globe-media-and-nielsen-to-conduct-unique-cross-platform-diversity-&-inclusion-brand-study

Boston Globe Media And Nielsen To Conduct Unique Cross-Platform Diversity & Inclusion Brand Study

atrium-health,-wake-forest-baptist-health,-wake-forest-school-of-medicine-and-renalytix-partner-to-advance-kidney-health

Atrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney Health

bioxcel-therapeutics-announces-fda-acceptance-for-filing-of-nda-for-bxcl501-for-the-acute-treatment-of-agitation-associated-with-schizophrenia-and-bipolar-disorders-i-and-ii

BioXcel Therapeutics Announces FDA Acceptance for Filing of NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders I and II

akamai-security-research:-financial-services-continues-getting-bombarded-with-credential-stuffing-and-web-application-attacks

Akamai Security Research: Financial Services Continues Getting Bombarded with Credential Stuffing and Web Application Attacks